233 related articles for article (PubMed ID: 21170754)
1. The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer.
Fowke JH; Motley SS; Barocas DA; Cookson MS; Concepcion R; Byerly S; Smith JA
Cancer Causes Control; 2011 Mar; 22(3):417-26. PubMed ID: 21170754
[TBL] [Abstract][Full Text] [Related]
2. Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study.
Freedland SJ; Hamilton RJ; Gerber L; Banez LL; Moreira DM; Andriole GL; Rittmaster RS
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):254-9. PubMed ID: 23567655
[TBL] [Abstract][Full Text] [Related]
3. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ
J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873
[TBL] [Abstract][Full Text] [Related]
4. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
Tarle M; Kraljić I
Anticancer Res; 1997; 17(3A):1531-4. PubMed ID: 9179191
[TBL] [Abstract][Full Text] [Related]
5. High grade intraepithelial neoplasia of prostate is associated with values of prostate specific antigen related parameters intermediate between prostate cancer and normal levels.
Obralic N; Kulovac B
Bosn J Basic Med Sci; 2011 Nov; 11(4):223-7. PubMed ID: 22117828
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of total and percent free prostate specific antigen in high grade prostatic intraepithelial neoplasia lesions: results of the Tyrol Prostate Specific Antigen Screening Project.
Horninger W; Volgger H; Rogatsch H; Strohmeyer D; Steiner H; Hobisch A; Klocker H; Bartsch G
J Urol; 2001 Apr; 165(4):1143-5. PubMed ID: 11257656
[TBL] [Abstract][Full Text] [Related]
7. Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma?
Raviv G; Zlotta AR; Janssen Th; Descamps F; Vanegas JP; Verhest A; Schulman CC
Cancer; 1996 May; 77(10):2103-8. PubMed ID: 8640677
[TBL] [Abstract][Full Text] [Related]
8. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies.
Rovner ES; Schanne FJ; Malkowicz SB; Wein AJ
J Urol; 1997 Jul; 158(1):138-41; discussion 141-2. PubMed ID: 9186340
[TBL] [Abstract][Full Text] [Related]
9. Statin use linked with a decrease in the conversion from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer.
Fowke JH; Motley SS
Carcinogenesis; 2018 May; 39(6):819-825. PubMed ID: 29617729
[TBL] [Abstract][Full Text] [Related]
10. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
[TBL] [Abstract][Full Text] [Related]
11. [Intraepithelial prostatic neoplasia].
Stepanov VN; Frank GA; Dzhioev RR
Urol Nefrol (Mosk); 1999; (1):16-9. PubMed ID: 11149338
[TBL] [Abstract][Full Text] [Related]
12. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
13. Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration.
Alexander EE; Qian J; Wollan PC; Myers RP; Bostwick DG
Urology; 1996 May; 47(5):693-8. PubMed ID: 8650867
[TBL] [Abstract][Full Text] [Related]
14. Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels.
Lefkowitz GK; Taneja SS; Brown J; Melamed J; Lepor H
J Urol; 2002 Oct; 168(4 Pt 1):1415-8. PubMed ID: 12352407
[TBL] [Abstract][Full Text] [Related]
15. Impact of PSA and DRE on histologic findings at prostate biopsy in Turkish men over 75 years of age.
Verim L; Yildirim A; Basok EK; Peltekoglu E; Pelit ES; Zemheri E; Tokuc R
Asian Pac J Cancer Prev; 2013; 14(10):6085-8. PubMed ID: 24289630
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
[TBL] [Abstract][Full Text] [Related]
17. Fluctuation in prostate cancer gene 3 (PCA3) score in men undergoing first or repeat prostate biopsies.
De Luca S; Passera R; Cappia S; Bollito E; Randone DF; Milillo A; Papotti M; Porpiglia F
BJU Int; 2014 Dec; 114(6b):E56-E61. PubMed ID: 24472071
[TBL] [Abstract][Full Text] [Related]
18. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
Goel T; Garg S
Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
[TBL] [Abstract][Full Text] [Related]
19. Use of prostate-specific antigen velocity to follow up patients with isolated high-grade prostatic intraepithelial neoplasia on prostate biopsy.
Loeb S; Roehl KA; Yu X; Han M; Catalona WJ
Urology; 2007 Jan; 69(1):108-12. PubMed ID: 17270629
[TBL] [Abstract][Full Text] [Related]
20. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy.
Kronz JD; Allan CH; Shaikh AA; Epstein JI
Am J Surg Pathol; 2001 Aug; 25(8):1079-85. PubMed ID: 11474294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]